Loading...
In 2022, the Endocrine Society, supported by five other endocrine and diabetes professional organizations, published a clinical practice guideline offering 15 recommendations for managing noncritically ill hospitalized adults. Additionally, in a new clinical trial, researchers assessed the intensity of correctional (i.e., “sliding-scale”) insulin therapy necessary for managing hospitalized patients with type 2 diabetes.
The guideline recommends (1) a broader target for blood glucose (BG) range and (2) differential use of correctional or scheduled insulin based on diabetes status prior to hospital admission. Hyperglycemic patients with no history of diabetes should receive correction insulin alone rather than scheduled insulin. Patients who h…